These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16522454)

  • 21. Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 microg bd versus fluticasone propionate 100 microg bd alone in patients with persistent asthma: integrated analysis of four randomised trials.
    Barnes NC; Jacques L; Goldfrad C; Bateman ED
    Respir Med; 2007 Nov; 101(11):2358-65. PubMed ID: 17689947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma].
    Beeh KM; Beier J; Kornmann O; Wiewrodt R; Buhl R;
    Pneumologie; 2002 Feb; 56(2):91-7. PubMed ID: 11842346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Call for withdrawal of LABA single-therapy inhaler in asthma.
    Beasley R; Perrin K; Weatherall M; Wijesinghe M
    Lancet; 2010 Sep; 376(9743):750-1. PubMed ID: 20816529
    [No Abstract]   [Full Text] [Related]  

  • 25. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics.
    Tarsin WY; Pearson SB; Assi KH; Chrystyn H
    Int J Pharm; 2006 Jun; 316(1-2):131-7. PubMed ID: 16584855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
    Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; Pétavy F; James M
    Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing asthma treatment.
    Zitt MJ; Rachelefsky GS
    N Engl J Med; 2007 Aug; 357(5):504-5; author reply 505-6. PubMed ID: 17674454
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fixed combination of salmeterol and fluticasone. A mile stone in asthma therapy].
    MMW Fortschr Med; 2002 Mar; 144(10):54. PubMed ID: 11928269
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma.
    Weersink EJ; Douma RR; Postma DS; Koëter GH
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1241-6. PubMed ID: 9105061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
    J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence to asthma controller medication regimens.
    Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A combination of fluticasone and salmeterol for asthma.
    Med Lett Drugs Ther; 2001 Apr; 43(1102):31-3. PubMed ID: 11309534
    [No Abstract]   [Full Text] [Related]  

  • 33. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
    Malone R; LaForce C; Nimmagadda S; Schoaf L; House K; Ellsworth A; Dorinsky P
    Ann Allergy Asthma Immunol; 2005 Jul; 95(1):66-71. PubMed ID: 16095144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y; Yasuba H; Kudou M; Kita H
    J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Salmeterol plus fluticasone--a powerful team. New combined preparation improves compliance].
    MMW Fortschr Med; 2001 Feb; 143(6):46-7. PubMed ID: 11247365
    [No Abstract]   [Full Text] [Related]  

  • 37. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fixed combination of inhalant steroids and long-acting beta(2) agonists].
    Petermann W; Mutschler E
    Dtsch Med Wochenschr; 2004 Jan; 129(5):210-4. PubMed ID: 14735419
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluticasone propionate/salmeterol combination.
    Lipworth BJ
    J Allergy Clin Immunol; 2001 Apr; 107(4):746. PubMed ID: 11295673
    [No Abstract]   [Full Text] [Related]  

  • 40. Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children.
    de Blic J; Ogorodova L; Klink R; Sidorenko I; Valiulis A; Hofman J; Bennedbaek O; Anderton S; Attali V; Desfougeres JL; Poterre M
    Pediatr Allergy Immunol; 2009 Dec; 20(8):763-71. PubMed ID: 19239660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.